This document is available in two formats: this web page (for browsing content) and PDF (comparable to original document formatting). To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site. For an official signed copy, please contact the Antitrust Documents Group.

View the related business review

U.S. Department of Justice Seal and Letterhead
FOR IMMEDIATE RELEASE
TUESDAY, MARCH 19, 1996
AT
(202) 616-2771
TDD (202) 514-1888


JUSTICE DEPARTMENT WILL NOT CHALLENGE MERGER
OF TWO NORTHERN MINNESOTA PHYSICIAN CLINICS

WASHINGTON, D.C. — The Department of Justice today said that it would not challenge the proposed merger of two small physician medical clinics located in rural Grand Rapids, Minnesota.

The Department's Antitrust Division said that given the rural setting of the market, the information provided by the parties about its operation, and the lack of any probable adverse competitive effect on managed care payers,the merger of the Itasca Clinic and Grand Rapids Medical Associates is not likely to substantially lessen competition.

The Department's position was stated in a business review letter from Assistant Attorney General Anne K. Bingaman, in charge of the Antitrust Division, to counsel for the two clinics.

The proposal would allow the eight-physician Itasca Clinic and the 13-physician Grand Rapids Medical Associates to merge.

Based substantially upon information presented by the clinics, the Department concluded that the merger should be analyzed for its effect in two relevant markets--primary care services provided by family practice doctors and internists, and general surgical services.

In those markets, Itasca Clinic employs about 15 percent and Grand Rapids Medical Associates employs about 25 percent of the physicians providing primary care services. Each employ about 16 percent of the general surgeons.

The Department said that although such a combination of physicians in a market could raise competitive concerns, in this instance no such concerns were expressed by third-party payers. Some payers believed the merger would result in improved access to medical care, the Department said.

Therefore, the Department does not intend to challenge the merger, although it reserves the right to bring an enforcement action if the merger should prove to have an anticompetitive effect.

Under the Department's business review procedure, an organization may submit a proposed action to the Antitrust Division and receive a statement as to whether the Division will challenge the action under the antitrust laws.

A file containing the business review request and the Department's response may be examined in the Legal Procedure Unit of the Antitrust Division, Suite 215 Liberty Place, 325 7th Street, N.W., Department of Justice, Washington, D.C. 20004.

After a 30-day waiting period, the documents supporting the business review will be added to the file, unless a basis for their confidentiality has been established pursuant to Paragraph 10(c) of the Business Review Procedure.

###

96-120